HARRIGAN EDMUND bought ACAD
May 29, 2026 · Form 4 insider transaction
HARRIGAN EDMUND bought 16,004 shares of ACADIA Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,004
Price
$0.00
Total value
N/A
InsiderHARRIGAN EDMUND
RoleDirector
SecurityDirector Stock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 29, 2026
Filing dateJune 1, 2026
Shares owned after16,004
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.